Targeted HIV Gene Therapy Using Zinc Finger Nucleases
Author Information
Author(s): Wayengera Misaki
Primary Institution: Makerere University
Hypothesis
Can zinc finger nucleases specifically disrupt HIV gene action to halt its replication?
Conclusion
Zinc finger nucleases may effectively disrupt HIV replication by excising a significant portion of proviral HIV DNA from infected cells.
Supporting Evidence
- Zinc finger nucleases can specifically target and cleave HIV DNA sequences.
- Lentiviral vectors are effective for delivering gene therapies to both dividing and non-dividing cells.
- Preclinical models showed potential for these nucleases to disrupt HIV replication.
Takeaway
This study explores a new way to fight HIV by using special proteins that can cut the virus's DNA, potentially stopping it from making more copies of itself.
Methodology
The study involved computational generation of zinc finger arrays and nucleases, followed by modeling lentiviral vectors for gene delivery and testing in preclinical models.
Potential Biases
The study may be biased towards the efficacy of zinc finger nucleases without extensive clinical validation.
Limitations
Potential genome toxicity and limited clinical trials of lentiviral vectors may hinder the technology's application in humans.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website